BioMarin Pharmaceutical
BMRN
#1731
Rank
A$17.57 B
Marketcap
A$90.76
Share price
-1.64%
Change (1 day)
11.37%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2026 (TTM): A-$0.14

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is A-$0.14. In 2025 the company made an earnings per share (EPS) of A$2.73 a decrease over its 2024 EPS that were of A$3.38.

EPS history for BioMarin Pharmaceutical from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.14-105.04%
2025A$2.73-19.11%
2024A$3.38152.81%
2023A$1.3415.79%
2022A$1.15-319.62%
2021A-$0.53-107.38%
2020A$7.12-3485.71%
2019A-$0.21-67.44%
2018A-$0.65-34.85%
2017A-$0.99-83.21%
2016A-$5.90263.89%
2015A-$1.6218.68%
2014A-$1.37
2012A-$1.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.98-2,300.59%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
A-$7.80 5,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A-$0.57 322.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.03005-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.17 22.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$2.72-2,111.11%๐Ÿ‡บ๐Ÿ‡ธ USA